Clinical trials
Precursor Cell Lymphoblastic Leukemia-Lymphoma trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 3 |
| 2008 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 8 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 5 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Hospital General de Mexico | 2 |
| National Research Center for Hematology, Russia | 2 |
| Anglia Ruskin University | 1 |
| Boston Children's Hospital | 1 |
| Cairo University | 1 |
| Children's Cancer Hospital Egypt 57357 | 1 |
| Children's Cancer and Leukaemia Group | 1 |
| Coordinación de Investigación en Salud, Mexico | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 35 |
| Leukemia | 5 |
| Leukemia, Myeloid, Acute | 3 |
| Congenital Abnormalities | 2 |
| Dendritic Cell Sarcoma, Interdigitating | 2 |
| Graft vs Host Disease | 2 |
| Kidney Neoplasms | 2 |
| Lymphoma | 2 |
| Myelodysplastic Syndromes | 2 |
| Myelodysplastic-Myeloproliferative Diseases | 2 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.